Aurobindo Pharma Ltd. (AUROPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 164981, "name": "Aurobindo Pharma", "stock_name": "Aurobindo Pharma", "full_name": "Aurobindo Pharma Ltd.", "name_url": "stocks-analysis/aurobindo-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,488.50", "chg": 9.95, "chgp": "0.67%", "dir": 1, "prev_price": "1,478.55", "mcapval": "86,563.00 Cr", "mcap": "Mid Cap", "scripcode": 524804, "symbol": "AUROPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE406A01037", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "10.58 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1504", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs1504-3981449", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3981449.png", "date": "2026-05-08 10:15:08", "description": "Surging to a fresh 52-week high of Rs 1504 on 8 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market despite a subdued Sensex. This milestone caps a 29.81% rally from its 52-week low of Rs 1017, underscoring the stock’s sustained technical strength across multiple timeframes." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1497.55", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs149755-3979212", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3979212.png", "date": "2026-05-07 09:40:05", "description": "With a decisive breakthrough to Rs 1497.55 on 7 May 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces the broader market’s modest gains." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1465", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs1465-on-6-may-2026-3977701", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3977701.png", "date": "2026-05-06 10:35:05", "description": "Surging to a fresh 52-week high of Rs 1465 on 6 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market with a 21.13% gain over the past year against the Sensex’s decline of 4.18%." }, { "title": "Aurobindo Pharma Ltd. is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-buy-by-marketsmojo-3969952", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_mojoScore_3969952.png", "date": "2026-04-30 10:10:38", "description": "Aurobindo Pharma Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 24 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Aurobindo Pharma Gains 2.03%: 6 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-203-6-key-factors-driving-the-weekly-rally-3963313", "imagepath": "", "date": "2026-04-26 14:01:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Apr:</strong> New 52-week high at Rs.1,396.6</p>\n <p><strong>21 Apr:</strong> All-time high reached at Rs.1,401</p>\n <p><strong>22 Apr:</strong> New 52-week high of Rs.1,415</p>\n <p><strong>23 Apr:</strong> New 52-week high at Rs.1,429.8</p>\n <p><strong>24 Apr:</strong> Week closes at Rs.1,413.8 (-1.54% on day)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,367.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat..." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1429.8", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs14298-3958684", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_priceRelatedfactors_3958684.png", "date": "2026-04-23 09:40:04", "description": "With a decisive break above Rs 1429.8 on 23 Apr 2026, Aurobindo Pharma Ltd. has reached a new 52-week high, extending its recent momentum amid a mixed broader market backdrop. The stock’s steady climb over the past three days, delivering a 4.2% gain, underscores a robust technical setup that has propelled it beyond key resistance levels." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1415", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs1415-on-22-apr-2026-3957540", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_priceRelatedfactors_3957540.png", "date": "2026-04-22 11:50:05", "description": "With a decisive surge to Rs 1415 on 22 Apr 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained upward movement across multiple timeframes, setting the stage for a compelling momentum narrative." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-3956383", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_oi_spurts_by_underlying_3956383.png", "date": "2026-04-21 15:00:06", "description": "Aurobindo Pharma Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock hit a new 52-week high of Rs 1,401.1 on 21 Apr 2026, outperforming its sector and reflecting renewed investor confidence amid robust volume and price action." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-3956134", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_oi_spurts_by_underlying_3956134.png", "date": "2026-04-21 14:00:06", "description": "Aurobindo Pharma Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting a notable shift in market sentiment and positioning. The stock hit a fresh 52-week high of Rs 1,401.1 on 21 Apr 2026, outperforming its sector and signalling renewed investor confidence amid evolving volume and price dynamics." } ], "total": 789, "sid": "164981", "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981" }, "announcements": [ { "caption": "US FDA Classification Of Unit-VII Of Aurobindo Pharma Limited As Voluntary Action Indicated (VAI)", "datetime": "06-May-2026", "details": "Intimation of classification of Unit VII of the Company by US FDA as Voluntary Action Indicated (VAI)", "source": "BSE" }, { "caption": "Intimation Of Resignation Of Dr. Sanjay Chaturvedi CEO Of Apitoria Pharma Private Limited Wholly Owned Subsidiary Of The Company", "datetime": "04-May-2026", "details": "Intimation of resignation of Dr. Sanjay Chaturvedi CEO of Apitoria Pharma Private Limited wholly owned subsidiary of the Company.", "source": "BSE" }, { "caption": "Curateq Biologics Secures Health Canada NOC For Bevqolva™ Bevacizumab Biosimilar", "datetime": "01-May-2026", "details": "This is to inform you that Curateq Biologics Private Limited a wholly owned subsidiary of the Company secures Health Canada NOC for Bevqolva Bevacizumab Biosimilar.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11", "dt": "2011-02-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15", "dt": "2015-07-20", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Apr: New 52-week high at Rs.1,396.6

21 Apr: All-time high reached at Rs.1,401

22 Apr: New 52-week high of Rs.1,415

23 Apr: New 52-week high at Rs.1,429.8

24 Apr: Week closes at Rs.1,413.8 (-1.54% on day)

Week Open

Rs.1,367.70

Week Close

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1429.8

2026-04-23 09:40:04

With a decisive break above Rs 1429.8 on 23 Apr 2026, Aurobindo Pharma Ltd. has reached a new 52-week high, extending its recent momentum amid a mixed broader market backdrop. The stock’s steady climb over the past three days, delivering a 4.2% gain, underscores a robust technical setup that has propelled it beyond key resistance levels.

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1415

2026-04-22 11:50:05

With a decisive surge to Rs 1415 on 22 Apr 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained upward movement across multiple timeframes, setting the stage for a compelling momentum narrative.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-04-21 15:00:06

Aurobindo Pharma Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock hit a new 52-week high of Rs 1,401.1 on 21 Apr 2026, outperforming its sector and reflecting renewed investor confidence amid robust volume and price action.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-04-21 14:00:06

Aurobindo Pharma Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting a notable shift in market sentiment and positioning. The stock hit a fresh 52-week high of Rs 1,401.1 on 21 Apr 2026, outperforming its sector and signalling renewed investor confidence amid evolving volume and price dynamics.

Read full news article